<VariationArchive VariationID="619030" VariationName="NM_000101.4(CYBA):c.246del (p.Phe83fs)" VariationType="Deletion" Accession="VCV000619030" Version="11" RecordType="classified" NumberOfSubmissions="4" NumberOfSubmitters="4" DateLastUpdated="2024-02-20" DateCreated="2019-02-24" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="610428" VariationID="619030">
      <GeneList>
        <Gene Symbol="CYBA" FullName="cytochrome b-245 alpha chain" GeneID="1535" HGNC_ID="HGNC:2577" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88643289" stop="88651053" display_start="88643289" display_stop="88651053" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88709696" stop="88717491" display_start="88709696" display_stop="88717491" Strand="-" />
          </Location>
          <OMIM>608508</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000101.4(CYBA):c.246del (p.Phe83fs)</Name>
      <CanonicalSPDI>NC_000016.10:88646795:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>16q24.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="88646796" stop="88646796" display_start="88646796" display_stop="88646796" variantLength="1" positionVCF="88646795" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="88713204" stop="88713204" display_start="88713204" display_stop="88713204" variantLength="1" positionVCF="88713203" referenceAlleleVCF="AG" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>F83fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000101.4" sequenceAccession="NM_000101" sequenceVersion="4" change="c.246delC" MANESelect="true">
            <Expression>NM_000101.4:c.246delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.88646798del" Assembly="GRCh38">
            <Expression>NC_000016.10:g.88646798del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.88713206del" Assembly="GRCh37">
            <Expression>NC_000016.9:g.88713206del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007291.1" sequenceAccession="NG_007291" sequenceVersion="1" change="g.9254del">
            <Expression>NG_007291.1:g.9254del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000101.4" sequenceAccession="NM_000101" sequenceVersion="4" change="c.246del" MANESelect="true">
            <Expression>NM_000101.4:c.246del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000092.2" sequenceAccession="NP_000092" sequenceVersion="2" change="p.Phe83fs">
            <Expression>NP_000092.2:p.Phe83fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_52" sequenceAccession="LRG_52">
            <Expression>LRG_52:g.9254del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_52t1" sequenceAccession="LRG_52t1">
            <Expression>LRG_52t1:c.246del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="608508.0002" DB="OMIM" />
        <XRef Type="rs" ID="1439134665" DB="dbSNP" />
      </XRefList>
      <FunctionalConsequence Value="protein loss of function">
        <XRef ID="0043" DB="Variation Ontology" />
      </FunctionalConsequence>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000101.4(CYBA):c.246del (p.Phe83fs) AND not provided" Accession="RCV001816812" Version="4">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-04-01" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000101.4(CYBA):c.246del (p.Phe83fs) AND Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative" Accession="RCV000757945" Version="8">
        <ClassifiedConditionList TraitSetID="578">
          <ClassifiedCondition DB="MedGen" ID="C1856255">Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-03" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-03" NumberOfSubmissions="4" NumberOfSubmitters="4" DateCreated="2019-02-24" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">2243141</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31364312</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">3571224</ID>
        </Citation>
        <DescriptionHistory Dated="2022-01-29">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="578" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1396" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative</ElementValue>
                <XRef ID="Granulomatous+disease%2C+chronic%2C+autosomal+recessive%2C+cytochrome+b-negative/8493" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009308" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CGD DUE TO DEFICIENCY OF THE ALPHA SUBUNIT OF CYTOCHROME b</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CGD, AUTOSOMAL RECESSIVE CYTOCHROME b-NEGATIVE</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CYBA DEFICIENCY</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4</ElementValue>
                <XRef Type="MIM" ID="233690" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0009" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0010" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0012" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0011" DB="OMIM" />
                <XRef Type="Allelic variant" ID="608508.0003" DB="OMIM" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15175" />
                <XRef ID="15175" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Chronic granulomatous disease (CGD) is a primary immunodeficiency disorder of phagocytes (neutrophils, monocytes, macrophages, and eosinophils) resulting from impaired killing of bacteria and fungi. CGD is characterized by severe recurrent bacterial and fungal infections and dysregulated inflammatory responses resulting in granuloma formation and other inflammatory disorders such as colitis. Infections typically involve the lung (pneumonia), lymph nodes (lymphadenitis), liver (abscess), bone (osteomyelitis), and skin (abscesses or cellulitis). Granulomas typically involve the genitourinary system (bladder) and gastrointestinal tract (often the pylorus initially, and later the esophagus, jejunum, ileum, cecum, rectum, and perirectal area). Some males with X-linked CGD have McLeod neuroacanthocytosis syndrome as the result of a contiguous gene deletion. While CGD may present anytime from infancy to late adulthood, the vast majority of affected individuals are diagnosed before age five years. Use of antimicrobial prophylaxis and therapy has greatly improved overall survival.</Attribute>
                <XRef ID="NBK99496" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">22876374</ID>
                <ID Source="BookShelf">NBK99496</ID>
              </Citation>
              <XRef ID="379" DB="Orphanet" />
              <XRef ID="C1856255" DB="MedGen" />
              <XRef ID="MONDO:0009308" DB="MONDO" />
              <XRef Type="MIM" ID="233690" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="22503" SubmissionDate="2020-07-06" DateLastUpdated="2020-07-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="608508.0002_GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4" title="CYBA, 1-BP DEL, 272C_GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4" />
        <ClinVarAccession Accession="SCV000022503" DateUpdated="2020-07-16" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="1990-11-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a patient with autosomal recessive cytochrome b-negative CGD (CGD4; 233690), Dinauer et al. (1990) identified compound heterozygous mutations in the CYBA gene: a 1-bp deletion (c.272delC), resulting in a frameshift and premature termination, and a c.297G-A transition, resulting in an arg90-to-gln (R90Q) substitution (608508.0003). The patient had previously been reported by Curnutte et al. (1987).</Attribute>
              <Citation>
                <ID Source="PubMed">2243141</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">3571224</ID>
              </Citation>
              <XRef DB="OMIM" ID="233690" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBA" />
          </GeneList>
          <Name>CYBA, 1-BP DEL, 272C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 272C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="608508.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1735431" SubmissionDate="2019-02-20" DateLastUpdated="2019-02-24" DateCreated="2019-02-24">
        <ClinVarSubmissionID localKey="SUB5161247" submittedAssembly="hg19" title="SUB5161247" />
        <ClinVarAccession Accession="SCV000882779" DateUpdated="2019-02-24" DateCreated="2019-02-24" Type="SCV" Version="1" SubmitterName="Blood Cell Research, Sanquin" OrgID="505752" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-02-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This patient was identified as a CGD patient by near absence of NADPH oxidase activity and absence of gp91phox expression in her neutrophils. Genetically this patient was a compound heterozygote for two different mutations in CYBA. On one allele she had a one-nucleotide deletion (c.246delC), inducing a shift in the reading frame that predicts termination of protein synthesis 108 codons downstream (p.Phe83LeufsTer108). On the other allele her CYBA gene contained a variation in intron 4, 15 nucleotides upstream of the start of exon 5 (c.288-15C&gt;G). Apparently, this variation created a cryptic splice site that was preferred over the original acceptor splice site, because cDNA analysis showed inclusion of 14 nucleotides from intron 4 (c.288-14_-1) into the mRNA. This mutation predicts p.Leu97ArgfsTer94.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Submitter's publication</Attribute>
          <Citation Type="general">
            <ID Source="pmc">4568122</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Ukrainian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBA">
              <Name>cytochrome b-245 alpha chain</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000101.4: exon 5</GeneLocation>
          </Location>
          <FunctionalConsequence Value="protein loss of function">
            <XRef DB="Variation Ontology" ID="0043" URL="http://purl.obolibrary.org/obo/VariO_0043" />
          </FunctionalConsequence>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000101.4:c.246delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="233690" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5161247</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4047305" SubmissionDate="2022-01-24" DateLastUpdated="2022-01-29" DateCreated="2022-01-29">
        <ClinVarSubmissionID localKey="NM_000101.2(CYBA):c.246del|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002064451" DateUpdated="2022-01-29" DateCreated="2022-01-29" Type="SCV" Version="1" SubmitterName="Genetic Services Laboratory, University of Chicago" OrgID="1238" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-04-01">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Comment>DNA sequence analysis of the CYBA gene demonstrated a single base pair deletion in exon 4, c.246del. This pathogenic sequence change results in an amino acid frameshift and creates a premature stop codon 107 amino acids downstream of the mutation, p.Phe83Leufs*108. This likely pathogenic sequence change is predicted to result in an abnormal transcript, which may be degraded, or may lead to the production of a truncated CYBA protein with potentially abnormal function. This pathogenic sequence change has previously been described in a patient with chronic granulomatous disease, in compound heterozygous state with a missense variant (PMID: 2243141).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000101.2:c.246del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10987670</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4261717" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="4933653|MedGen:C1856255" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002241463" DateUpdated="2024-02-14" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">2243141</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31364312</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Phe83Leufs*108) in the CYBA gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 113 amino acid(s) of the CYBA protein. This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individuals with chronic granulomatous disease (PMID: 2243141, 31364312). This variant is also known as 'C-272 deletion'. ClinVar contains an entry for this variant (Variation ID: 619030). This variant disrupts a region of the CYBA protein in which other variant(s) (p.Ile116Leufs*75) have been determined to be pathogenic (Invitae). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CYBA" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000016.9:g.88713204del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1856255" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="22503" TraitType="Disease" MappingType="Name" MappingValue="GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, 4" MappingRef="Preferred">
        <MedGen CUI="C1856255" Name="Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1735431" TraitType="Disease" MappingType="XRef" MappingValue="233690" MappingRef="OMIM">
        <MedGen CUI="C1856255" Name="Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4047305" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4261717" TraitType="Disease" MappingType="XRef" MappingValue="C1856255" MappingRef="MedGen">
        <MedGen CUI="C1856255" Name="Granulomatous disease, chronic, autosomal recessive, cytochrome b-negative" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

